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Abstract: (1) Introduction: Due to the non-invasive nature of saliva, many methods have been used to
isolate and collect DNA from saliva samples for microbial screening. Many oral microbes also inhabit
the oral biofilm, which may represent significantly different microbial constituents that may contribute
to oral health and disease, including caries and periodontal disorders. Moreover, the biofilm may vary
within the same patient at different sites. Few studies have evaluated the comparison between DNA
isolated from saliva and DNA from site-specific biofilm, with virtually no studies addressing this
analysis among pediatric patients. (2) Methods: An existing repository of paper point derived biofilm,
gingival crevicular fluid (GCF), and unstimulated saliva samples previously collected from pediatric
patients (n = 47) was identified. DNA was isolated from biofilm sites (tongue, upper buccal molar,
mandibular lingual incisor), and GCF and saliva were used for quantitative DNA comparison using
a phenol:chloroform extraction. A quantitative and qualitative analysis was performed using the
NanoDrop 2000 spectrophotometer using absorbance readings at A230 nm, A260 nm and A280 nm.
(3) Results: These data demonstrated the successful isolation of DNA from all of the patient samples,
with the highest concentrations observed among unstimulated saliva (4264.1 ng/µL) and the lowest
derived from GCF (1771.5 ng/µL). No differences were observed between males and females or
minorities and non-minority patients. In addition, comparison of the overall concentrations of
DNA obtained from adult samples was slightly higher than, but not significantly different from,
the concentrations obtained from pediatric samples (p = 0.2827). A real-time quantitative qPCR
screening revealed that all of the samples evaluated harbored bacterial and human DNA of sufficient
quantity and quality for a molecular screening greater than the limit of detection (∆Rn = 0.01).
(4) Conclusions: Many methods are currently available to provide the sampling and screening of
saliva and specific sites within the oral cavity, but the validation and comparison of simple and
low-cost methods, that include paper point sampling and unstimulated saliva collection, may suggest
these methods and protocols provide sufficient DNA quality and quantity for molecular screening and
other comparison applications. In addition, although heterogeneity will be a constant and consistent
feature between patient samples, standardized methods that provide similar and consistent DNA
from various oral sites may provide needed consistency for screening and molecular analysis.
Keywords: saliva screening; gingival crevicular fluid; oral biofilm; paper point sampling;
DNA isolation
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1. Introduction
Due to the non-invasive nature of saliva collection, many methods have been used to isolate and
collect DNA from saliva samples for microbial screening [1–3]. Screening methods for these samples
have included highly specific and technical procedures involving immunofluorescence microscopy,
proteomic analysis and next-generation sequencing [3–6]. Among the most sensitive, rapid, reliable
and widely available methods for oral microbial screening is the polymerase chain reaction (PCR) [7,8].
Although a few studies have made detailed analyses from DNA isolated from saliva and other oral
fluids, such as gingival crevicular fluid (GCF), as well as oral biofilm comparisons and analyses [9,10],
to date there have been virtually no comparisons with oral site-specific biofilms to determine the
comparative quality and quantity for a subsequent microbial PCR screening [11].
Many oral microbes also inhabit the oral biofilm, which may represent significantly different
microbial constituents that may contribute to oral health and disease [12,13]. The production and
growth of oral biofilms are implicated in oral diseases, including caries and periodontal disorders [14,15].
Therefore, the sampling and analysis of oral biofilms may also represent a significant source of readily
available, non-invasive data regarding oral health and disease [16,17].
Although a previous study from this group evaluated the comparison between DNA isolated
from saliva or GCF with DNA from site-specific biofilm in adults [11], virtually no studies addressing
this analysis among pediatric patients have been completed. Based upon this lack of analytic data,
the primary goal of this study was to make a quantitative and qualitative comparison to determine the
suitability of the DNA from these oral samples for microbial PCR screening.
2. Methods
2.1. Study Approval
This was a retrospective analysis of previously collected saliva and oral samples. The protocol for
this study was reviewed and approved exempt by the University of Nevada Las Vegas Office for the
Protection of Research Subjects (OPRS) on 6 February 2015 under Protocol#1502-506M. The original
protocol OPRS#1305-4466M “The Prevalence of Oral Microbes in Saliva from the UNLV School of Dental
Medicine Pediatric and Adult Clinical Population” was approved on 31 May 2013. These protocols
(and OPRS approval) comply with the Health Information Portability and Accountability Act (HIPAA)
standards for the privacy of individually identifiable health information (Privacy Rule), issued by the
United States Department of Health and Human Services (HHS).
2.2. Original Sample Collection
From the original protocol, patients (or parents/guardians if the patient was under 18 years of
age) were asked for their voluntary participation. Any patient or parent/guardian that declined to
participate was excluded. Patients were asked to provide informed consent. If patients were under
18 years of age, patients were asked to provide pediatric assent with the parent/guardian providing
informed consent. No patients were given money or services for their participation.
Each patient was then given a sterile saliva collection tube and were requested to produce up to
five mL of unstimulated saliva. Gingival crevicular fluid was acquired from the buccal gingival crevice
of the maxillary central incisor using sterile paper points (Size 40 Quality Endodontic Distributors,
QED) for a standardized three minutes. Biofilm samples were acquired from the dorsum of the tongue,
supragingival biofilm on the buccal surface of the first upper molar (maxillary), and lingual surface
of the central incisor (mandibular), as previously described [11]. Each sample was stored on ice and
transferred to a biomedical biosafety level 2 (BSL-2) laboratory for long-term storage and processing.
Samples from each patient were given a randomly generated, non-duplicated number to avoid any
specific patient information or other identifying information from being associated with each sample.
Only basic demographic information, such as age, sex and race/ethnicity, was noted.
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2.3. DNA Isolation
Samples were thawed and DNA was isolated using the phenol:choloform extraction method with
TRIzol reagent (Invitrogen) specifically designed to isolate high-quality nucleic acids (RNA, DNA) from
tissues or fluids, as previously described [18,19]. In brief, 100 µL of thawed saliva was removed for
analysis. For each paper point sample, 100 µL of sterile 1X phosphate buffered saline (PBS) was added to
each paper point containing sample collection tubes and was vortexed to release any microbial or human
cells. This solution was added to 300 µL of TRIzol reagent prior to incubation. After five minutes, 200 µL
of chloroform was added and incubated for an additional five minutes. Each sample was subsequently
centrifuged at 12,000× g, or the relative centrifugal force (RCF), for fifteen minutes at 4 ◦C.
The nucleic acid-containing phase was transferred to a new microcentrifuge tube with the addition
of 100% isopropanol, which was gently mixed to precipitate the nucleic acids from the solution.
These samples were then centrifuged for an additional five minutes to pellet the DNA. The supernatant
was aspirated and the pellet washed with 100% ethanol and was centrifuged for an additional five
minutes. The ethanol was aspirated and the DNA pellet was resuspended in 100µL of DNA rehydration
solution for analysis. Negative controls for liquid samples, including saliva and GCF (distilled water),
as well as for paper points (sterile/blank paper points), were used where appropriate.
2.4. DNA Analysis
The concentration and purity of the DNA was determined using the NanoDrop spectrophotometer
(ThermoFisher) with absorbance readings at 260 and 280 nm. An estimation of the DNA concentration
can be obtained using the absorbance at A260 nm and the correction for turbidity at A320 nm, adjusting
for the dilution factor. An estimation of the purity can be determined from the ratio of A260 nm and
A280 nm with the corresponding dilution factor. High quality DNA will correspond with a ratio of
A260:A280, ranging between 1.7–2.0. Absorbance at A230 was also measured to provide the A260:A230
ratio—commonly accepted as an accurate measure of the residual chemical contamination from nucleic
acid extraction procedures. Expected values typically range from approximately 2.0 to 2.2 for “pure”
nucleic acid samples acceptable for qPCR analysis and screening.
2.5. qPCR Screening
Screening for the presence of microbial and human DNA was accomplished using a quantitative
polymerase chain reaction (qPCR) using primers for bacterial 16S rRNA and human glyceraldehyde
3-phosphate dehydrogenase (GAPDH), with specifications that included an initial incubation at 50 ◦C
for two minutes, followed by denaturation at 95 ◦C for 10 min, and 25 cycles: denaturation at 95 ◦C for
15 s and annealing at 51 ◦C for one minute. The reaction included: 15 µL TaqMan universal PCR master
mix (Applied Biosystems), 0.6 µL of the following primers at a concentration of 10 uM from Eurofins
MWG Operon (Huntsville, AL), and 0.75 µL of probe resulting in a final probe concentration of 0.2 uM,
with 2 µL of the DNA samples. Sterile, nuclease-free distilled water from Promega (Madison, WI, USA)
was used to adjust the final reaction volume to 30 µL. Each screening was performed in duplicate.
The primers synthesized from Eurofins MWG Operon (Huntsville, AL, USA) were:
(Nucleotide = nt; Tm = melting temperature)
Bacterial 16S rRNA
Forward 16S rRNA universal primer, 5′-ACGCGTCGACAGAGTTTGATCCTGGCT-3′
27 nt, 56% GC, Tm 76 ◦C
Reverse 16S rRNA universal primer, 5′-GGGACTACCAGGGTATCTAAT-3′
21 nt, 48% GC, Tm 62 ◦C
16S probe: (6-FAM)-5′-CGTATTACCGCGGCTGCTGGCAC-3′-(TAMRA)
23 nt, 65% GC, Tm 76 ◦C
Human glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
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Forward primer-GAPDH, 5′-ATCTTCCAGGAGCGAGATCC-3′
20 nt, 55% GC, Tm 66 ◦C
Reverse primer-GAPDH, 5′- ACCACTGACACGTTGGCAGT-3′
20 nt, 55% GC, Tm 70 ◦C
GAPDH probe: (6-FAM)-5′-CCTCTACTGGCGCTGCCAAGGCT-3′-(TAMRA)
23 nt, 65% GC, Tm 77 ◦C
2.6. qPCR Analysis
Results from the real-time qPCR screening were analyzed using the delta (∆) normalized reported
(Rn) value or ∆Rn. To obtain this value, the fluorescent signal from each qPCR reaction is normalized
to the signal from the passive (unincorporated) reference dye by dividing the qPCR signal by the
passive reference dye signal. The delta Rn value is then obtained by finding the difference between the
normalized Rn value minus the baseline signal generated by the specific qPCR instrument. This analysis
can be used to reliably calculate the magnitude of the specific signal produced by any given set of
qPCR conditions above the threshold limit of detection (∆Rn = 0.01).
2.7. Statistical Analysis
DNA measurements involve continuous parametric data, therefore descriptive statistics regarding
these data were given where appropriate (mean and the standard error of the mean (SEM)).
Graphic analysis of data was visualized using box-and-whisker plots, which included using the
Tukey method to plot the interquartile range (IQR) between the 25th and 75th percentiles, as previously
described [11]. Any differences between the concentrations or purity between the samples or oral
sites were measured using Student’s t-tests, which are appropriate for the analysis of parametric data.
Due to the confounding influence of multiple two-way t-tests, the analysis of variance (ANOVA) was
used to confirm all statistical analyses.
A demographic analysis of the study sample was performed using simple descriptive statistics
(raw number and percentage of the overall sample) for comparison with overall clinic averages using
the categorical variables (sex, race/ethnicity). Differences between categorical variables can be most
appropriately analyzed using Chi Square (χ2) analysis, reporting the degrees of freedom (d.f.) and
resulting p-values.
3. Results
A quantitative and qualitative analysis of DNA was successfully completed from all the
cryopreserved patient samples, n = 47 (Table 1). The oral sites with the overall highest DNA
concentrations were derived from unstimulated saliva (average 4264.1 ng/µL), which were significantly
different from all other sites (p = 0.0348). All three of the sites sampling biofilm (the dorsum tongue,
upper buccal and mandibular lingual) had averages (2382.4 ng/µL, 20148.4 ng/µL and 2428.6 ng/µL,
respectively) that were not significantly different from one another (p = 0.5376). The oral site with the
overall lowest DNA concentrations were derived from the gingival crevicular fluid (GCF; average
1771.5 ng/µL), which was not significantly different from those derived from the biofilm (p = 0.4805).
In addition, DNA purity was measured using A260:A280 ratios, which was fairly consistent among all
the sampling sites with averages ranging between 1.71 and 1.82. Because some individual samples
had A260:A280 ratios as low as 1.55, absorbance at A230 was also measured to provide the A260:A230
ratio–commonly accepted as an accurate measure of the residual chemical contamination from nucleic
acid extraction procedures. These results demonstrated a fairly low residual contamination, with values
ranging from 1.92 to 2.01 that closely approximates the expected values between 2.0 and 2.2 for “pure”
nucleic acid samples acceptable for qPCR analysis and screening.
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Table 1. Quantitative and qualitative analysis of oral site sampling.







































1771.5 ± 245.9 ng/µL 1669.2 ng/µL p = 0.4805 1.71 ± 0.22(range: 1.60–1.98)
1.96 ± 0.08
(range: 1.89–2.05)
To visualize these data, box-and-whisker plots were created to evaluate the minimum, maximum,
first and third quartile ranges (Figure 1). These data clearly demonstrate the similarity between
the median and means of the non-salivary samples revealed by the data from Table 1. In addition,
this demonstrated further similarity between the first quartile ranges of the tongue, upper buccal,
mandibular lingual and GCF (713.4–1057.0 ng/µL) and third quartiles ranges (2214.6–3055.1 ng/µL),
which were markedly different from those of unstimulated saliva (1588.2–6198.8 ng/µL).Methods Protoc. 2020, 3, x FOR PEER REVIEW 6 of 11 
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Figure 1. Box-and-whisker plot analysis of DNA from oral sampling sites. The Tukey method used to
plot the interquartile range (IQR) between the 25th and 75th percentile reveals similarities between the
DNA concentrations derived from biofilm and GCF, which were significantly lower than those derived
from unstimulated saliva (p = 0.0348).
To evalu te whet r the results obtained from the cryopreserv d samples were similar to the
results obtained from the fr sh samples taken during the same study [11], the average conce trations
from the original samples (fresh) w re plotted against those from the current study (frozen) to determi e
if th quivalent saliva s mple volumes yielded similar amounts of DNA (Figure 2). These data
demonstrated that, although the overall c ncentration of DNA obtained from the original (fresh) saliva
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samples was slightly higher, this was not significantly different from the concentrations obtained
from the pediatric samples (cryopreserved: 4264.1 ng/µL, original (fresh): 4809.3 ng/µL (p = 0.5389)).
In addition, comparison of the DNA obtained from gingival crevicular fluid also exhibited similar
results, which were also not significantly different (cryopreserved: 1762 ng/µL, original (fresh):
2639.5 ng/µL (p = 0.2253)).
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samples. A box-and-whisker plot analysis of data demonstrates a broader range of DNA concentrations
among frozen samples when compared with fresh samples, with roughly similar averages (4264.1 ng/µL
and 4809.3 ng/µL, p = 0.5389), and gingival crevicular fluid (1762 ng/µL and 2639.5 ng/µL, p = 0.2253).
The concentrations from the surface biofilm samples from the frozen and original (fresh) samples
were graphed for comparison (Figure 3). These data demonstrated that the overall DNA concentration
isolated from the original (fresh) biofilm samples was higher than, and significantly different from,
the concentrations obtained from the cryopreserved samples (p = 0.0308). More specifically, the average
DNA concentrations from the tongue biofilm, upper buccal molar and lingual incisor from frozen
samples (2382 ng/µL, 2048 ng/µL, 2428 ng/µL, respectively) were significantly different from those of
the original (fresh) samples (3049 ng/µL, 2838.1 ng/µL, 2894.9 ng/µL, respectively (p = 0.0308)).
A real-time qPCR was performed to evaluate the presence of bacterial (16S rRNA) and human
(GAPDH) DNA from the salivary and GCF isolates (Figure 4). The qPCR screening revealed that all
the samples evaluated harbored bacterial and human DNA of sufficient quantity and quality for a
molecular screening greater than the limit of detection (∆Rn = 0.01). No significant differences in the
qPCR signal intensity for 16S or GAPDH were found between the cryopreserved and original samples
(p = 0.7401).
Finally, to determine if there are any study-specific biases within the original sample collection,
simple descriptive statistics of the demographic characteristics were assembled for analysis (Table 2).
These data demonstrated a significantly lower proportion of females in the study sample versus the
overall percentage of females from the pediatric clinic population, from which they were originally
obtained (36.2% and 52.8%, respectively (p = 0.0012)). In addition, the proportion of samples derived
from non-minority (white) patients was significantly lower than the overall percentage from the
pediatric clinic population (4.25% and 24.7%, respectively (p = 0.00018)).
Methods Protoc. 2020, 3, 48 7 of 10
Methods Protoc. 2020, 3, x FOR PEER REVIEW 7 of 11 
 
samples. A box-and-whisker plot analysis of data demonstrates a broader range of DNA 
concentrations among frozen samples when compared with fresh samples, with roughly similar 
averages (4264.1 ng/μL and 4809.3 ng/μL, p = 0.5389), and gingival crevicular fluid (1762 ng/μL and 
2639.5 ng/μL, p = 0.2253). 
The concentrations from the surface biofilm samples from the frozen and original (fresh) 
samples were graphed for comparison (Figure 3). These data demonstrated that the overall DNA 
concentration isolated from the original (fresh) biofilm samples was higher than, and significantly 
different from, the concentrations obtained from the cryopreserved samples (p = 0.0308). More 
specifically, the average DNA concentrations from the tongue biofilm, upper buccal molar and 
lingual incisor from frozen samples (2382 ng/μL, 2048 ng/μL, 2428 ng/μL, respectively) were 
significantly different from those of the original (fresh) samples (3049 ng/μL, 2838.1 ng/μL, 2894.9 
ng/μL, respectively (p = 0.0308)). 
 
Figure 3. Comparison of the DNA concentrations isolated from the frozen and original (fresh) biofilm 
samples. Graphic display of representative samples (n = 10) demonstrated a slightly broader range of 
DNA concentrations among the original (fresh) samples compared with cryopreserved samples, with 
higher averages among the original (fresh) samples. Original (fresh): 2927.3 ng/μL and cryopreserved: 
2286.5 ng/μL (p = 0.0308). 
A real-time qPCR was performed to evaluate the presence of bacterial (16S rRNA) and human 
(GAPDH) DNA from the salivary and GCF isolates (Figure 4). The qPCR screening revealed that all 
the samples evaluated harbored bacterial and human DNA of sufficient quantity and quality for a 
molecular screening greater than the limit of detection (ΔRn = 0.01). No significant differences in the 
qPCR signal intensity for 16S or GAPDH were found between the cryopreserved and original 
samples (p = 0.7401). 
Figure 3. Comparison of the DNA concentrations isolated from the frozen and original (fresh)
biofilm samples. Graphic display of re rese tative samples (n = 10) demonstrated a slightly broader
range of DNA concentrations among the original (fresh) samples compared with cryopreserved
samples, with higher averages among the original (fresh) samples. Original (fresh): 2927.3 ng/µL and
cryopreserved: 2286.5 ng/µL (p = 0.0308).Methods Protoc. 2020, 3, x FOR PEER REVIEW 8 of 11 
 
 
Figure 4. A real-time qPCR screening of cryopreserved and original (fresh) saliva, as well as GCF 
samples. Screening using universal 16S rRNA bacterial primers and GAPDH human glycolytic 
pathway primers revealed positive results above the limit of detection (ΔRn = 0.01) with no significant 
differences in the signal intensity for 16S or GAPDH between the cryopreserved and original samples 
(p = 0.7401). 
Finally, to determine if there are any study-specific biases within the original sample collection, 
simple descriptive statistics of the demographic characteristics were assembled for analysis (Table 2). 
These data demonstrated a significantly lower proportion of females in the study sample versus the 
overall percentage of females from the pediatric clinic population, from which they were originally 
obtained (36.2% and 52.8%, respectively (p = 0.0012)). In addition, the proportion of samples derived 
from non-minority (white) patients was significantly lower than the overall percentage from the 
pediatric clinic population (4.25% and 24.7%, respectively (p = 0.00018)). 
Table 2. Demographic analysis of study samples. 
Demographic Study Sample Clinic Statistical Analysis 
Sex    
Female n = 17/47 (36.2%) 52.8% Χ2 = 110.571, d.f. = 1 
Male n = 30/47 (63.8%) 47.2% p = 0.0012 
Race/Ethnicity    
White (non-Minority) n = 2/47 (4.25%) 24.7% Χ2 = 223.753, d.f. = 1 
Minority n = 45/47 (95.75%) 75.3% p = 0.00018 
Hispanic n = 35/47 (74.5%) 52.1%  
Black n = 8/47 (17%) 11.8%  
Asian/Other n = 2/47 (4.25%) 11.4%  
Age    
Average age 10.26 years 11.34 years  
Age range 5—15 years 0—18 years  
Figure 4. A real-time qPCR screening of cryopreserved and original (fresh) saliva, as well as GCF
samples. Screening using universal 16S rRNA bacterial primers and GAPDH human glycolytic pathway
primers revealed positive results above the limit of detection (∆Rn = 0.01) with no significant differences
in the signal intensity for 16S or GAPDH between the cryopreserved and original samples (p = 0.7401).
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Table 2. Demographic analysis of study samples.
Demographic Study Sample Clinic Statistical Analysis
Sex
Female n = 17/47 (36.2%) 52.8% X2 = 110.571, d.f. = 1
Male n = 30/47 (63.8%) 47.2% p = 0.0012
Race/Ethnicity
White (non-Minority) n = 2/47 (4.25%) 24.7% X2 = 223.753, d.f. = 1
Minority n = 45/47 (95.75%) 75.3% p = 0.00018
Hispanic n = 35/47 (74.5%) 52.1%
Black n = 8/47 (17%) 11.8%
Asian/Other n = 2/47 (4.25%) 11.4%
Age
Average age 10.26 years 11.34 years
Age range 5—15 years 0—18 years
4. Discussion
Although evaluations of DNA isolated from saliva or GCF and site-specific biofilm have been
performed in adults [11], the primary goal of this study was to make a quantitative and qualitative
comparison to determine the suitability of the DNA from pediatric oral samples for microbial PCR
screening. These data provide the first quantitative and qualitative data that suggest sampling of the
oral biofilm among pediatric patients using paper points may provide consistent and high quality
results from a variety of patients and oral site locations—a novel finding that may expand the range of
institutions and research groups that may contribute to the advancement of oral health research [20,21].
In addition, only a very limited number of studies have provided an in depth analysis and
comparisons of pediatric and adult biofilm samples [22,23]. This study provides direct comparisons of
DNA concentrations not only from unstimulated saliva and GCF, but also from the biofilm derived
from several distinct oral sites. Although many efforts have been made to describe changes to the oral
biofilm over time in either pediatric or adult patients, these studies may be both cost prohibitive and
time consuming—which may delay the discovery and development of relevant findings to help reduce
the burden of oral disease [24,25].
As the need for standardized approaches becomes more evident, the validation of standardized
protocols and methods using commonly available dental office materials becomes a research priority [26].
This study provides preliminary evidence that contributes to the development of these protocols and
methods and also provides comparisons of pediatric and adult samples from different oral biofilm sites.
However, this study sample was limited in number due to financial and other site-specific limitations.
Future research in this area should include larger comparison samples that may provide more robust
evidence for quantitative and qualitative evaluation.
5. Conclusions
Many methods are currently available to provide the sampling and screening of saliva and specific
sites within the oral cavity, but the validation and comparison of simple and low-cost methods that
include paper point sampling and unstimulated saliva collection may suggest that these methods and
protocols provide sufficient DNA quality and quantity for molecular screening and other comparison
applications. In addition, although heterogeneity will be a constant and consistent feature between
patient samples, standardized methods that provide similar and consistent DNA from various oral
sites may provide the needed consistency for screening and molecular analysis.
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